Invention Grant
US09175345B2 Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
有权
使用基因组测试和致酮化合物治疗降低的认知功能
- Patent Title: Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
- Patent Title (中): 使用基因组测试和致酮化合物治疗降低的认知功能
-
Application No.: US12671610Application Date: 2008-07-31
-
Publication No.: US09175345B2Publication Date: 2015-11-03
- Inventor: Samuel T. Henderson
- Applicant: Samuel T. Henderson
- Applicant Address: US CO Broomfield
- Assignee: Accera, Inc.
- Current Assignee: Accera, Inc.
- Current Assignee Address: US CO Broomfield
- Agency: Swanson & Bratschun, L.L.C.
- International Application: PCT/US2008/071817 WO 20080731
- International Announcement: WO2009/018478 WO 20090205
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34
Abstract:
This invention relates to methods of using genotyping to select patients for treatment with compounds capable of elevating ketone body concentrations in amounts effective to treat reduced neuronal metabolism associated with reduced neuronal metabolism, for example Alzheimer's disease.
Public/Granted literature
- US20110243885A1 Use of Genomic Testing and Ketogenic Compounds for Treatment of Reduced Cognitive Function Public/Granted day:2011-10-06
Information query
